175 related articles for article (PubMed ID: 2930689)
1. Metoclopramide enhances the effect of cisplatin on xenografted squamous cell carcinoma of the head and neck.
Kjellén E; Wennerberg J; Pero R
Br J Cancer; 1989 Feb; 59(2):247-50. PubMed ID: 2930689
[TBL] [Abstract][Full Text] [Related]
2. The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
Sasaki Y; Kjellén E; Ekblad L; Wahlberg P; Mineta H; Wennerberg J
Oral Oncol; 2012 Jan; 48(1):61-6. PubMed ID: 21963040
[TBL] [Abstract][Full Text] [Related]
3. Metoclopramide enhances the effect of ionizing radiation on xenografted squamous cell carcinoma of the head and neck.
Lybak S; Kjellén E; Wennerberg J; Pero R
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1419-24. PubMed ID: 2262366
[TBL] [Abstract][Full Text] [Related]
4. Dose schedule evaluation of metoclopramide as a potentiator of cisplatin and carboplatin treatments of xenografted squamous cell carcinomas of the head and neck.
Lybak S; Wennerberg J; Kjellén E; Pero RW
Anticancer Drugs; 1991 Aug; 2(4):375-82. PubMed ID: 1797194
[TBL] [Abstract][Full Text] [Related]
5. Biochemical modulation of chemotherapy and radiotherapy in head and neck cancer.
Wennerberg J; Kjellén E; Lybak S; Rydell R; Pero R
Anticancer Res; 1993; 13(6B):2501-6. PubMed ID: 8135490
[TBL] [Abstract][Full Text] [Related]
6. The effect of cisplatin and fluorouracil on xenografted human squamous cell carcinoma of the head and neck.
Wennerberg J; Biörklund A; Tropé C
Arch Otolaryngol Head Neck Surg; 1988 Feb; 114(2):162-7. PubMed ID: 3337774
[TBL] [Abstract][Full Text] [Related]
7. Metoclopramide as a modulator of cisplatin: effects on pharmacokinetcs and cisplatin-DNA adducts in tumor and normal tissue.
Johnsson A; Kjellén E; Wennerberg J; Pero R
Anticancer Drugs; 1996 Jun; 7(4):483-8. PubMed ID: 8826617
[TBL] [Abstract][Full Text] [Related]
8. Pegylated liposome-encapsulated doxorubicin and cisplatin in the treatment of head and neck xenograft tumours.
Harrington KJ; Rowlinson-Busza G; Uster PS; Stewart JS
Cancer Chemother Pharmacol; 2000; 46(1):10-8. PubMed ID: 10912572
[TBL] [Abstract][Full Text] [Related]
9. Metoclopramide enhances the effect of photodynamic therapy on xenografted human squamous cell carcinoma of the head and neck.
Werning JW; Stepnick DW; Jafri A; Megerian CA; Antunez AR; Zaidi SI
Arch Otolaryngol Head Neck Surg; 1995 Jul; 121(7):783-9. PubMed ID: 7598858
[TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect of the angiogenesis inhibitor, TNP470, on squamous cell carcinoma cells in head and neck cancer].
Kawano T; Furukawa S; Matsuda H; Takahashi M; Endo R; Inoue M; Nishimura G; Tsukuda M
Nihon Jibiinkoka Gakkai Kaiho; 2000 Jul; 103(7):821-8. PubMed ID: 10946555
[TBL] [Abstract][Full Text] [Related]
11. [Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
Sugasawa M; Nibu K; Ichimura K; Kaga K; Asai M; Senba T; Yamasoba T; Tsunoda K; Abe K; Kobayashi T
Gan To Kagaku Ryoho; 1994 Jun; 21(7):969-74. PubMed ID: 8002635
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-fluorouracil interaction in a squamous cell carcinoma xenograft.
Rydell R; Wennerberg J
Arch Otolaryngol Head Neck Surg; 1990 Oct; 116(10):1172-6. PubMed ID: 2206502
[TBL] [Abstract][Full Text] [Related]
13. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the anticancer agent cisplatin in the treatment of human cervical squamous carcinoma xenografted in nude mice.
Pillay CV; Green-Thompson R; Brock-Utne JG
Chemotherapy; 1986; 32(4):356-63. PubMed ID: 3731921
[TBL] [Abstract][Full Text] [Related]
15. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
Gustafsson H; Kale A; Dasu A; Lund A; Edqvist PH; Roberg K
Cell Biochem Biophys; 2017 Dec; 75(3-4):299-309. PubMed ID: 28756482
[TBL] [Abstract][Full Text] [Related]
16. Pulsed Radiation Therapy With Concurrent Cisplatin Results in Superior Tumor Growth Delay in a Head and Neck Squamous Cell Carcinoma Murine Model.
Meyer K; Krueger SA; Kane JL; Wilson TG; Hanna A; Dabjan M; Hege KM; Wilson GD; Grills I; Marples B
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):161-9. PubMed ID: 27511853
[TBL] [Abstract][Full Text] [Related]
17. Sensitization by glycerol for CDDP-therapy against human cultured cancer cells and tumors bearing mutated p53 gene.
Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Yane K; Kanata H; Okamoto N; Hosoi H; Ohnishi T
Apoptosis; 2004 Nov; 9(6):853-9. PubMed ID: 15505427
[TBL] [Abstract][Full Text] [Related]
18. [Low-dose CDDP and 5-FU for head and neck cancer patients].
Fujii M; Kanke M; Tomita T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Lamph WW; Heyman RA; Hayes JS; Thomazy V; Davies PJ
Clin Cancer Res; 1996 Mar; 2(3):511-20. PubMed ID: 9816198
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
